Lincoln Pharmaceuticals Ltd - Stock Valuation and Financial Performance

BSE: 531633 | NSE: LINCOLN | Pharmaceuticals & Drugs | Small Cap

Lincoln Pharma Share Price

688 5.70 0.84%
as on 31-Oct'24 16:01

DeciZen - make an informed investing decision on Lincoln Pharma

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Semi Strong

incoln Pharmaceuticals stock performance -

mw4me loader
P/E Ratio (SA):
13.91
Market Cap:
1,362.4 Cr.
52-wk low:
477.9
52-wk high:
814

Is Lincoln Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Lincoln Pharmaceuticals Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Lincoln Pharmaceuticals Ltd is a good quality company.

2. Is Lincoln Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Lincoln Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Lincoln Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Lincoln Pharmaceuticals Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Lincoln Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Lincoln Pharmaceuticals Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 16.5%19.8%18.6%18.3%21.7%21.8%25.2%24.3%21.8%22.5%-
Value Creation
Index
0.20.40.30.30.60.60.80.70.60.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 223311304325353376423472510581592
Sales YoY Gr.-39.2%-2.1%6.8%8.6%6.5%12.5%11.6%8.1%13.8%-
Adj EPS 8.212.213.615.121.821.630.733.932.344.548.9
YoY Gr.-48.5%11.8%10.8%44.5%-0.9%42.1%10.5%-4.7%37.6%-
BVPS (₹) 68.380.494.8109.8131.3152.3182.9216.1250.9296307.8
Adj Net
Profit
13.419.927.230.243.643.261.56864.889.198
Cash Flow from Ops. 8.828.917.821.351.170.769.476.239.263.2-
Debt/CF from Ops. 5.52.132.60.70.1000.10-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 11.2%10.5%11.1%13.8%
Adj EPS 20.7%15.3%13.2%37.6%
BVPS17.7%17.7%17.4%18%
Share Price 30.1% 33.5% 25.6% 39.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
12.715.916.614.818.115.218.31713.916.316.2
Op. Profit
Mgn %
10.510.61414.217.115.920.620.317.517.317.2
Net Profit
Mgn %
66.499.312.411.514.614.412.715.416.5
Debt to
Equity
0.40.50.30.30.100000-
Working Cap
Days
248168198221223227227226231225134
Cash Conv.
Cycle
108939394908063647986104

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 16.20%

Sales growth is growing at healthy rate in last 3 years 11.14%

Net Profit is growing at healthy rate in last 3 years 13.15%

Sales growth is good in last 4 quarters at 13.93%

No data to display

Latest Financials - Lincoln Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 48.9 48.9
TTM Sales (₹ Cr.) 592 592
BVPS (₹.) 307.8 307.8
Reserves (₹ Cr.) 596 596
P/BV 2.21 2.21
PE 13.91 13.91
From the Market
52 Week Low / High (₹) 477.85 / 814.00
All Time Low / High (₹) 8.05 / 814.00
Market Cap (₹ Cr.) 1,362
Equity (₹ Cr.) 20
Face Value (₹) 10
Industry PE 46.8

Management X-Ray of Lincoln Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Lincoln Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales223311304325353376423472510581
Operating Expenses 200278262279293317336377421481
Manufacturing Costs232932394548697896113
Material Costs131189158152157163155170179204
Employee Cost 162735484855638093103
Other Costs 30343741425049505360
Operating Profit 233342466059879589100
Operating Profit Margin (%) 10.3%10.5%13.9%14.1%17.1%15.8%20.6%20.2%17.5%17.2%
Other Income 56367126102234
Interest 6654422121
Depreciation 33445588911
Exceptional Items 0000000000
Profit Before Tax 1930364358648496100122
Tax 48810121421272829
Profit After Tax 15222733475062697393
PAT Margin (%) 6.6%7.0%9.0%10.1%13.2%13.2%14.7%14.7%14.3%16.1%
Adjusted EPS (₹)9.113.313.716.423.324.831.134.636.446.6
Dividend Payout Ratio (%)11%8%9%9%6%6%5%4%4%4%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 111131190220263304366433502593
Share Capital 16162020202020202020
Reserves 95115170200243284346413482573
Minority Interest0000000000
Debt485951553240221
Long Term Debt0976210000
Short Term Debt485044493040221
Trade Payables13212535364257715172
Others Liabilities 23313332476178798159
Total Liabilities 195242299341378412501585636725

Fixed Assets

Gross Block51807291101108142171197237
Accumulated Depreciation181748121731394757
Net Fixed Assets336368838891111132151179
CWIP 33702021673
Investments 132036394660819791139
Inventories19253236293847737077
Trade Receivables8275799611391112115135161
Cash Equivalents 655871113183413
Others Assets3951727891121136134148152
Total Assets 195242299341378412501585636725

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 9291821517169763963
PBT 1930364358648496100122
Adjustment 788875510-17
Changes in Working Capital -14-3-17-2131502-31-16
Tax Paid -3-6-9-9-17-14-19-24-30-26
Cash Flow From Investing Activity -5-40-26-14-22-29-64-78-37-57
Capex -4-33-17-9-11-6-9-45-14-40
Net Investments 00-101-6-15-44-23-4-3
Others -1-71-5-5-8-11-9-19-15
Cash Flow From Financing Activity -5118-4-30-38-6-3-5-5
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 08-2-1-4-3-1-100
Interest Paid -4-6-5-4-4-2-1-1-1-1
Dividend Paid -1-2-2-3-4-70-3-3-3
Others 010174-18-26-420-1
Net Cash Flow -1004-14-1-4-21
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)14.0417.9417.0916.0119.3517.4818.5617.3515.5917.04
ROCE (%)16.4619.8318.6318.2821.6821.8125.2124.2921.8222.53
Asset Turnover Ratio1.091.451.141.021.010.990.960.910.880.89
PAT to CFO Conversion(x)0.61.320.670.641.091.421.111.10.530.68
Working Capital Days
Receivable Days1369191981059685838590
Inventory Days32253438333135444945
Payable Days893353728287116138124110

Lincoln Pharmaceuticals Ltd Stock News

Lincoln Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Lincoln Pharma on 31-Oct-2024 16:01 is ₹688.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Oct-2024 16:01 the market cap of Lincoln Pharma stood at ₹1,362.4.
The latest P/E ratio of Lincoln Pharma as of 31-Oct-2024 16:01 is 13.91.
The latest P/B ratio of Lincoln Pharma as of 31-Oct-2024 16:01 is 2.21.
The 52-week high of Lincoln Pharma is ₹814.0 and the 52-week low is ₹477.9.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Lincoln Pharma is ₹592.2 ( Cr.) .

About Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals was established in 1979 to manufacture and market affordable therapeutic products. Since then, Lincoln Pharmaceuticals has come a long way.

Lincoln Pharmaceuticals is a public limited company with a large shareholder base including members of the medical fraternity. It has its own manufacturing facilities, covering all the major dosage forms, like tablets, capsules, injectables, syrups, Ointments, etc. Its present manufacturing activities are located near Ahmedabad. The plant spreads across 30,000 square meters. There are three different buildings for tablets, capsules and injectables and also a separate building for quality control.

An ultramodern laboratory with state-of-the-art equipments ensures in-house quality assurance of each of the products. The products are designed for all therapeutic segments with a special emphasis on gynecological and orthopedic specialties.

Group of Companies

  • Lincoln Parenterals
  • Karnavati Distributors
  • Down Town Travels
  • Shelavi Paper Mills

Product of the company

  • Tablets 
  • Capsules
  • Injectables
  • Syrups
  • Ointments

Certification

  • WHO-GMP standard
  • ISO 9002 certification 
  • Export House certification
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.